ResearchSafe

Generic semaglutide is still way off for most of us, and that matters

Posted by amber464 in Weight Loss & Metabolic - 4 points, 0 comments.

https://www.nbcnews.com/health/health-news/generic-ozempic-united-states-limitation-drug-patents-india-canada-rcna344737

NBC is talking about why a cheaper generic Ozempic may show up in some countries sooner, but the U.S. likely won’t see one until at least 2031. That’s the part people keep glossing over when they act like pricing is about to magically get normal here.

I’m honestly annoyed by how much hype gets tossed around like lower costs are right around the corner. For folks trying to stay on semaglutide long term, or even just titrate without getting price gouged, that timeline is the whole story. It also lines up with what I’ve seen in the real world, a lot of people stall at lower doses, then get stuck choosing between paying out the nose or quitting. As a lab tech, I care about the boring stuff, access, continuity, and whether people can actually stay on something long enough to see if it helps.

Anybody else think the patent mess is basically the bigger weight-loss story than the drugs themselves right now?

Community discussion - research and educational context only. Not medical advice.